Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
YAZ in Chinese women for contraception and acne
NCT02710708Phase 4Completed
- Sponsor
- Bayer
- Start
- May 2016
- Primary completion
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ethinyl estradiol + drospirenone in contraception, acne vulgaris, dysmenorrhea, sponsored by Bayer. Started May 2016; status: completed.
02
Drugs
ethinyl estradiol + drospirenone
03
Conditions
contraceptionacne vulgarisdysmenorrhea
Beyond the preview
Go deeper on NCT02710708.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02710708.